“We report on the development of a rapid, field-deployable Cas13a-based penA mosaic assay that accurately detected the absence of mosaicism in the penA gene of N. gonorrhoeae. The assay demonstrated promising correlation with phenotypic cefixime susceptibility. Integration into the portable DxHub platform could enable point-of-care use in field settings (…)”
Read More“Mpox SHINE performed on the DxHub demonstrates how CRISPR-based pathogen detection can be rapidly translated into portable tools for the front lines of outbreak response.”
Read MoreUnder the contract, DxLab will adapt its DxHub platform to enable rapid, clinically actionable testing of key infectious diseases at the point-of-care for the U.S. Air Force
Read More